A Risk-Benefit Assessment of Treatment with Finasteride in Benign Prostatic Hyperplasia

    January 1998 in “ Drug safety
    Peter Ekman
    TLDR Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.
    The document assessed the risk-benefit profile of finasteride for treating benign prostatic hyperplasia (BPH). Finasteride reduced serum 5α-DHT levels by 80%, leading to a 20-25% reduction in prostate size and a 30% improvement in prostatic symptoms over 6 months, with effects lasting up to 6 years. However, it was less effective than the α-blocker terazosin in a double-blind study and showed significant benefits only in patients with prostate glands larger than 40ml. Finasteride was well tolerated, with a 3-4% incidence of impotence and some cases of decreased ejaculatory volume and gynaecomastia. Early intervention with finasteride could reduce the need for surgical procedures over a 2-year period.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community How come topical finasteride even works at all?

      in Finasteride/Dutasteride  29 upvotes 4 months ago
      Topical finasteride can effectively reduce scalp DHT by targeting local enzymes, despite less systemic impact compared to oral forms. Combining oral dutasteride with topical finasteride and minoxidil may enhance hair loss prevention, though evidence of its effectiveness is limited.

      community Is finasteride better than dutasteride?

      in Finasteride/Dutasteride  31 upvotes 7 months ago
      Dutasteride reduces DHT more effectively than finasteride, but finasteride is more commonly used and approved for hair loss. Users have mixed opinions on dutasteride's effectiveness, with some experiencing better results and others facing side effects or no improvement.

    Related Research

    2 / 2 results